← FDA Drug Approvals (Drugs@FDA)
AMOXICILLIN AND CLAVULANATE POTASSIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2023-12-08
Drug application
- FDA Application #
ANDA217805
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMOXICILLIN AND CLAVULANATE POTASSIUM
- Generic name
- AMOXICILLIN AND CLAVULANATE POTASSIUM
- Active ingredients
- AMOXICILLIN; CLAVULANATE POTASSIUM
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MICRO LABS
- Manufacturer
- Micro Labs Limited
- First approval
- 2023-12-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown